Second‐line treatments in children with immune thrombocytopenia: Effect on platelet count and patient‐centered outcomes-Reference-Cited by-同舟云学术

Second‐line treatments in children with immune thrombocytopenia: Effect on platelet count and patient‐centered outcomes

Published:2019-04-29 Issue: Volume: Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Grace Rachael F.¹^ORCID,Shimano Kristin A.²,Bhat Rukhmi³,Neunert Cindy⁴,Bussel James B.⁵,Klaassen Robert J.⁶,Lambert Michele P.⁷^ORCID,Rothman Jennifer A.⁸,Breakey Vicky R.⁹,Hege Kerry¹⁰,Bennett Carolyn M.¹¹,Rose Melissa J.¹²,Haley Kristina M.¹³^ORCID,Buchanan George R.¹⁴,Geddis Amy¹⁵,Lorenzana Adonis¹⁶,Jeng Michael¹⁷,Pastore Yves D.¹⁸,Crary Shelley E.¹⁹,Neier Michelle²⁰,Neufeld Ellis J.²¹,Neu Nolan¹,Forbes Peter W.²²,Despotovic Jenny M.²³

Affiliation:

1. Division of Hematology/OncologyDana‐Farber/Boston Children's Cancer and Blood Disorder Center Boston Massachusetts

2. Division of Pediatric Allergy, Immunology, and Bone Marrow TransplantationUCSF Benioff Children's Hospital San Francisco California

3. Center for Cancer & Blood Disorders, Ann and Robert H. Lurie Childrens Hospital of ChicagoFeinberg School of Medicine, Northwestern University Chicago Illinois

4. Division of Hematology, Oncology, and Stem Cell TransplantColumbia University Medical School New York New York

5. Department of PediatricsWeill Cornell Medicine New York New York

6. Division of Hematology/OncologyChildren's Hospital of Eastern Ontario Ottawa Ontario Canada

7. Division of HematologyThe Children's Hospital of Philadelphia Philadelphia Pennsylvania

8. Division of Pediatric Hematology/OncologyDuke University Medical Center Durham North Carolina

9. Division of Pediatric Hematology/OncologyMcMaster University Hamilton Ontario Canada

10. Division of Pediatric Hematology/Oncology, Riley Hospital at IU HealthIndiana University School of Medicine Indianapolis Indiana

11. Division of Hematology/Oncology, Aflac Cancer and Blood Disorders CenterEmory University School of Medicine, Children's Healthcare of Atlanta Atlanta Georgia

12. Division of Hematology, Oncology, and Bone Marrow Transplant, Nationwide Children's HospitalThe Ohio State University College of Medicine Columbus Ohio

13. Division of Pediatric HematologyOregon Health & Science University Portland Oregon

14. Division of Hematology‐OncologyUniversity of Texas Southwestern Medical Center Dallas Texas

15. Division of Pediatric Hematology/OncologyUniversity of Washington, Seattle Children's Hospital Seattle Washington

16. Division of Pediatric Hematology/OncologySt. John Ascension Hospital Detroit Michigan

17. Department of PediatricsStanford School of Medicine Palo Alto California

18. Division of Hematology/OncologyCHU Sainte‐Justine Montreal Québec Canada

19. Department of PediatricsUniversity of Arkansas for Medical Sciences Little Rock Arkansas

20. Division of Pediatric Hematology/OncologyGoryeb Children's Hospital Morristown New Jersey

21. Division of HematologySt. Jude Children's Research Hospital Memphis Tennessee

22. Clinical Research CenterBoston Children's Hospital Boston Massachusetts

23. Department of PediatricsHematology/Oncology Section, Baylor College of Medicine Houston Texas

Funder

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25479

Reference17 articles.

1. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group;Rodeghiero F;Blood,2009

2. The American Society of Hematology 2011 evidence‐based practice guideline for immune thrombocytopenia;Neunert C;Blood,2011

3. A comparative prospective observational study of children and adults with immune thrombocytopenia: 2‐year follow‐up;Schifferli A;Am J Hematol,2018

4. Second‐line therapies in immune thrombocytopenia;Grace RF;Hematology Am Soc Hematol Educ Program,2016

5. Thrombopoietin receptor agonist use in children: data from the pediatric ITP consortium of North America ICON2 study;Neunert C;Pediatr Blood Cancer,2016

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lightening the load for paediatric ITP: The importance of health‐related quality of life;British Journal of Haematology;2024-08-27

2. Quality of life in childhood immune thrombocytopenia: Revision of the Kids' ITP Tools (KIT);British Journal of Haematology;2024-07-27

3. Face validity of the Kids’ ITP Tools (KIT) in the era of thrombopoietin receptor agonists;Pediatric Blood & Cancer;2024-01-24

4. Second-line treatment for pediatric patients with immune thrombocytopenia;Japanese Journal of Thrombosis and Hemostasis;2024

5. A proposal for new definition (s) and management approach to paediatric refractory ITP: Reflections from the Intercontinental ITP Study Group;British Journal of Haematology;2023-08-29